Balyasny Asset Management L.P.
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1218710
Chicago, IL
Position in AQST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,097,269
-$8,940,096 QoQ
Shares Held
744,536
-74.3% QoQ
Ownership
0.593%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 185 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Derivatives in AQST
reported options exposure · as of Sep 30, 2025CallValue
$2,795,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. AQST ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in AQST
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,097,269 | 744,536 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,037,365 | 2,900,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,272,265 | 970,939 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,795,000 | 500,000 | Call | Sole | 2025-11-14 | |
| 2024-09-30 | $144,106 | 28,937 | Shares | Sole | 2024-11-14 | |
| 2021-09-30 | $645,545 | 148,061 | Shares | Sole | 2021-12-01 | |
| No filing history on record for this holder in this stock. | ||||||